# TME Alteration in HER2 Positive Breast Cancer

> **NCT06533670** · — · ACTIVE_NOT_RECRUITING · sponsor: **Seoul National University Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Breast Cancer
- HER2-positive Breast Cancer
- Chemotherapy Effect

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06533670
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-07-19
- **Primary completion:** 2026-07-19
- **Final completion:** 2026-07-19
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06533670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06533670, "TME Alteration in HER2 Positive Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06533670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*